Top White House scientist resigns after review finds he demeaned staff
By Tyler Pager,
The Washington Post
| 02. 07. 2022
"Keynote speaker Eric Lander 1" by afagen
is licensed under CC BY-SA 2.0
Eric Lander, President Biden’s top science adviser, resigned Monday night after he acknowledged mistreating his subordinates and apologized for demeaning them, a pattern of behavior that put him at odds with one of Biden’s earliest promises — to run an administration marked by respect and professionalism.
An internal review by the White House found credible evidence that Lander, director of the Office of Science and Technology Policy, bullied staff in violation of the White House’s “safe and respectful workplace policy,” which was intended in part to draw a contrast with the Trump administration.
Lander’s resignation came after the White House struggled throughout the day to explain why he had not quit or been fired, and how that squared with a pledge Biden made on his first day in office. On that day, he told staffers at swearing-in ceremony, “If you are ever working with me and I hear you treat another colleague with disrespect, talk down to someone, I promise you I will fire you on...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Briana Contreras, Managed Healthcare Executive | 06.17.2025